Literature DB >> 27638008

Influence of contraceptive choice on vaginal bacterial and fungal microflora.

G Donders1,2,3,4, G Bellen5, D Janssens6, B Van Bulck7, P Hinoul7, J Verguts8,9.   

Abstract

The influence of contraception on vaginal microflora can have a major impact on the risk of developing acute or recurrent vaginal infections, but also may influence the risk of acquiring sexually transmissible infections (STI) such as HIV. A cohort of 248 women presenting for levonorgestrel-releasing intrauterine system (LNG-IUS) insertion or reinsertion were stratified according to their current contraceptive method. Information concerning their menstrual pattern and data about the medical history were collected. The composition of their vaginal microflora was studied by detailed phase contrast microscopy of fresh vaginal fluid, and aerobic cultures were taken to detect enteric bacterial growth and fungal colonisation. LNG-IUS and progesterone-only-pill (POP) users had significantly lower blood loss (p < 0.001) than other women. Regardless of the type of contraception used, all women reported similar rates of symptomatic lower genital tract infection during the preceding year. Women using combined oral contraception (COC) and long-term LNG-IUS had the same bacterial composition of vaginal microflora as non-contraceptive users, even when infections were combined. Both hormonal and non-hormonal intrauterine device users had an increased tendency to have more vaginal colonisation with Candida. Women on POPs or subcutaneous implants had a tendency towards increased vaginal atrophy, but had a lower Candida carriage rate compared to IUCD users (LNG-IUS and Copper-IUCD, p = 0.037). Women with an increased risk of acquiring STIs or recurrent BV could benefit from LNG-IUS or COC due to a well-preserved vaginal bacterial flora. Women with a susceptibility for RVVC should prefer POPs, and avoid intrauterine contraception.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27638008     DOI: 10.1007/s10096-016-2768-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS).

Authors:  Trícia Lessard; José A Simões; Michelle G Discacciati; Margarete Hidalgo; Luis Bahamondes
Journal:  Contraception       Date:  2007-11-26       Impact factor: 3.375

2.  Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis.

Authors:  Gilbert G G Donders; Annie Vereecken; Eugene Bosmans; Alfons Dekeersmaecker; Geert Salembier; Bernard Spitz
Journal:  BJOG       Date:  2002-01       Impact factor: 6.531

Review 3.  Aerobic vaginitis in pregnancy.

Authors:  Ggg Donders; G Bellen; D Rezeberga
Journal:  BJOG       Date:  2011-06-14       Impact factor: 6.531

Review 4.  Definition and classification of abnormal vaginal flora.

Authors:  Gilbert G G Donders
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2007-04-16       Impact factor: 5.237

5.  A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships.

Authors:  Renee Heffron; Edwin Were; Connie Celum; Nelly Mugo; Kenneth Ngure; James Kiarie; Jared M Baeten
Journal:  Sex Transm Dis       Date:  2010-10       Impact factor: 2.830

Review 6.  Nonbarrier contraceptives and vaginitis and vaginosis.

Authors:  S Roy
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

7.  Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis.

Authors:  T Nohmi; S Abe; K Dobashi; S Tansho; H Yamaguchi
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

8.  Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.

Authors:  Janneke H H M van de Wijgert; Peter H Kilmarx; Heidi E Jones; John M Karon; Supaporn Chaikummao
Journal:  Contraception       Date:  2007-12-27       Impact factor: 3.375

9.  Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections.

Authors:  Raquel Ferraz do Lago; Jose A Simões; Luis Bahamondes; Rodrigo P S Camargo; Marcos Perrotti; Ilza Monteiro
Journal:  Contraception       Date:  2003-08       Impact factor: 3.375

10.  Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence.

Authors:  C Tibaldi; N Cappello; M A Latino; G Masuelli; S Marini; C Benedetto
Journal:  Clin Microbiol Infect       Date:  2009-06-24       Impact factor: 8.067

View more
  8 in total

Review 1.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

2.  Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study.

Authors:  Kathryn Peebles; Flavia M Kiweewa; Thesla Palanee-Phillips; Catherine Chappell; Devika Singh; Katherine E Bunge; Logashvari Naidoo; Bonus Makanani; Nitesha Jeenarain; Doerieyah Reynolds; Sharon L Hillier; Elizabeth R Brown; Jared M Baeten; Jennifer E Balkus
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

Review 3.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

4.  Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.

Authors:  Lisa B Haddad; Kristin M Wall; Katherine Tote; William Kilembe; Bellington Vwailika; Tyronza Sharkey; Ilene Brill; Elwyn Chomba; Amanda Tichacek; Susan Allen
Journal:  Obstet Gynecol       Date:  2019-09       Impact factor: 7.623

5.  The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle.

Authors:  Maria Christine Krog; Luisa W Hugerth; Emma Fransson; Zahra Bashir; Anders Nyboe Andersen; Gabriella Edfeldt; Lars Engstrand; Ina Schuppe-Koistinen; Henriette Svarre Nielsen
Journal:  Hum Reprod       Date:  2022-06-30       Impact factor: 6.353

6.  Associations between sexual habits, menstrual hygiene practices, demographics and the vaginal microbiome as revealed by Bayesian network analysis.

Authors:  Noelle Noyes; Kyu-Chul Cho; Jacques Ravel; Larry J Forney; Zaid Abdo
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

Review 7.  Interplay Between the Host, the Human Microbiome, and Drug Metabolism.

Authors:  Robert G Nichols; Jeffrey M Peters; Andrew D Patterson
Journal:  Hum Genomics       Date:  2019-06-11       Impact factor: 4.639

8.  Temporal Dynamics of the Adult Female Lower Urinary Tract Microbiota.

Authors:  Travis K Price; Birte Wolff; Thomas Halverson; Roberto Limeira; Linda Brubaker; Qunfeng Dong; Elizabeth R Mueller; Alan J Wolfe
Journal:  mBio       Date:  2020-04-21       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.